Loading...
Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis
A 58-year-old man with chronic kidney disease (CKD) was admitted to our hospital for hemodialysis (HD) therapy. He had been administered allopurinol (100 mg/day) before hospitalization, and we replaced it with febuxostat (10 mg/day), a new xanthine oxidase inhibitor. Levels of aspartate aminotransfe...
Na minha lista:
| Udgivet i: | CEN Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Japan
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5411563/ https://ncbi.nlm.nih.gov/pubmed/28509193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-014-0109-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|